根据香港交易所披露的最新权益变动信息，全球资管巨头贝莱德于6月5日增持了国药控股的H股股份。其持有的好仓（长仓）权益比例，已从之前的8.84%显著提升至9.86%。这一变动反映了国际大型投资机构对中国医药流通龙头企业的持续关注与信心。
根据香港交易所披露的最新权益变动信息，全球资管巨头贝莱德于6月5日增持了国药控股的H股股份。其持有的好仓（长仓）权益比例，已从之前的8.84%显著提升至9.86%。这一变动反映了国际大型投资机构对中国医药流通龙头企业的持续关注与信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.